Are we finally winning the war on cancer?
Cutler
David M
DM
Department of Economics and Kennedy School of Government, Harvard University, and National Bureau of Economic Research, Cambridge, Massachusetts, USA. dcutler@harvard.edu
D001943:Breast Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D003113:Colonoscopy / Q000191:economics; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D003362:Cost-Benefit Analysis; D005260:Female; D005544:Forecasting; D006801:Humans; D008017:Life Expectancy / Q000639:trends; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D008297:Male; D008327:Mammography / Q000191:economics; D009026:Mortality / Q000639:trends; D009369:Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D009780:Occult Blood; D011314:Preventive Health Services / Q000191:economics; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D019057:Quality-Adjusted Life Years; D012812:Sigmoidoscopy / Q000191:economics; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000150:complications; D014057:Tomography, X-Ray Computed / Q000191:economics; D014481:United States / Q000453:epidemiology
D017430:Prostate-Specific Antigen